Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
Talazoparib Plus Enzalutamide for HRR Gene-Altered mCRPC Receives FDA Approval
Source – FDA On June 20, 2023, the combination of talazoparib (Talzenna) and enzalutamide (Xtandi) has been approved by the ...
Takeda Unveils Complete Phase III Trial Results for HYQVIA as Maintenance Therapy in CIDP at PNS Annual Meeting
Source: Takeda Takeda on June 20, 2023, released the complete findings from the pivotal Phase III ADVANCE-CIDP 1 clinical trial, ...
Argenx receives FDA approval for the first gMG subcutaneous treatment
Source – Argenx Argenx has claimed an FDA clearance that might increase its market share in the increasingly competitive market ...
CDC advisory group reviews GSK and Pfizer RSV vaccinations
Source – Fierce Pharma On June 21, 2023, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease ...
Vyvanse Joins Adderall in Short Supply as Takeda’s Rival Faces Shortages
Source – Fierce Pharma A competitor medication from Takeda is currently in low supply after a lengthy scarcity of the ...
The US FDA has approved the use of Jardiance (empagliflozin) to treat type II diabetes in children and adolescents aged 10 and older
Source – Eli Lilly On June 21, 2023, Boehringer Ingelheim and Eli Lilly and Company announced that the US Food ...
BioSenic’s stock declines as it discontinues bone-repair treatment
Source – BioSenic A Phase II b study of ALLOB, a stem cell-derived treatment intended to quicken bone fracture repair, ...
Boehringer Ingelheim’s Zantac arbitration is won by Sanofi
Source – Sanofi On 20 June 2023 in Paris, Sanofi reports that the International Chamber of Commerce tribunal has rejected ...
Rani’s ‘robotic’ tablet administers an injection of an osteoporosis medication
Source – Rani Therapeutics In a first-in-human research, US biotech Rani Therapeutics demonstrated that its oral version of an osteoporosis ...
High Cost of New Cancer Drugs and Lack of Awareness Impede Adoption in the US
A new survey conducted by healthcare research firm Sermo revealed that oncologists in the United States perceive pricing as the ...
A monovalent COVID booster is advised by the FDA advisory group
The FDA advisory panel recently reached a unanimous conclusion regarding COVID-19 vaccinations for the upcoming autumn. They recommended a transition ...
FDA Accepts sNDA for NALIRIFOX as First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma
Source: Ipsen Pharma The FDA has accepted a supplemental new drug application (sNDA) for the combination of liposomal irinotecan, 5-fluorouracil, ...
Merck Completes Acquisition of Prometheus Biosciences, Expanding Pipeline with Potential Breakthrough Treatment
Source: Merck On June 16, 2023, Merck announced the successful completion of its acquisition of Prometheus Biosciences, making Prometheus a ...
Keytruda Triumphs: Promising Progression-Free Survival in HER2-Positive Gastric Cancer
Source: Merck Merck’s renowned cancer drug, Keytruda, may soon see an updated label for its effectiveness in treating HER2-positive stomach ...
Groundbreaking Clinical Trial Confirms Effectiveness of Emgality in Preventing Episodic Migraines
Source: Eli Lilly and Company On June 16, 2023, Eli Lilly and Company released the findings of the CHALLENGE-MIG clinical ...
The FDA supports a biomarker for aggressive fibrotic tumors
Source: Nordic Bio The FDA has granted its backing to a blood test that may be able to determine if ...
AbbVie claims that Coherus violated the Humira patent settlement by working with Mark Cuban’s pharmaceutical company
AbbVie says that Coherus breached a licensing agreement that controls the commercialization of the biosimilar in a regulatory filing. The ...
FDA committee to talk about choosing the right strain for the subsequent round of COVID-19 boosts
Source – FDA The FDA’s Advisory Committee on Vaccines and Related Biological Products will meet on 15 June to discuss ...
Ex-baseball player hired by AbbVie to help de-stigmatize bowel condition as part of their post-Humira growth strategy
In his second season playing professional baseball, Fowler, who won the World Series with the Chicago Cubs in 2016, had ...
In a heated dispute over blood cancer treatment, AbbVie sues BeiGene over a brand-new Imbruvica patent
AbbVie’s Pharmacyclics division claims that BeiGene’s Bruki Nsa violates a patent on its blood cancer medication Imbruvica in a recent ...
Skyrizi from AbbVie wins a maintenance trial for ulcerative colitis and is poised to receive FDA approval
Source – Abbvie On 16 June 2023, Risankizumab (SKYRIZI, 180 mg or 360 mg subcutaneous [SC]) achieved the primary endpoint ...
Glofitamab-gxbm receives FDA approval for relapsing or resistant DLBCL
Source – Roche Columvi (Glofitamab-gxbm) has been given expedited clearance by the FDA for the treatment of adult patients with ...
98% ORR in Early-Stage Classical Hodgkin Lymphoma with Brentuximab Vedotin + Nivolumab/Chemo
Source – Seagen Frontline treatment with the combination of brentuximab vedotin (Adcetris), nivolumab (Opdivo), doxorubicin, and dacarbazine led to an ...
FDA Prolongates PDUFA Nirogacestat’s NDA for desmoid tumors is three months
Source – SpringWorks According to SpringWorks Therapeutics on June 7, 2023, the FDA has extended the Prescription Drug User Fee ...
Clinical Activity is Induced by Ziftomenib in NPM1-mutant R/R AML
Source – Kura Oncology Phase I data from the KOMET-001 trial (NCT04067336) showed that treatment with Ziftomenib, a menin-MLL (KMT2A) ...
Companion Diagnostic for Encorafenib + Cetuximab in BRAF V600E alteration in mCRC Receives FDA Approval
Source – Foundation Medicine In order to identify patients with metastatic colorectal cancer (mCRC) who could be candidates to receive ...
Kura makes a $100 million offer when AML is caused by a Menin inhibitor
Source – Kura Oncology Safety problems had previously slowed down the development of Kura Oncology’s Menin inhibitor Ziftomenib for acute ...
Trial of 2seventy Bio’s AML cell treatment was put on hold following a death
Source – 2seventy bio On June 14, 2023, as a result of Seattle Children’s Therapeutics pausing a clinical study of ...
To support women’s health programmes in Latin America and the Caribbean, Organon partners with a bank
Source: Organon Organon, a women’s health company, set objectives for increasing access to healthcare last summer in its inaugural environmental, ...
Acadia plans a Phase III study for a Prader-Willi syndrome candidate following an FDA meeting
Source – Acadia Pharmaceuticals ACP-101, also known as intranasal carbetocin, has been chosen by Acadia to move forward into a ...
